The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Acquired gene alteration patterns and post-progression survival: PARADIGM study analysis.
 
Hiroyuki Uetake
No Relationships to Disclose
 
Riu Yamashita
Consulting or Advisory Role - Takeda
 
Kohei Shitara
Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Janssen; Lilly; Ono Pharmaceutical
Consulting or Advisory Role - ALX Oncology; Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo; Guardant Health; MSD; Novartis; Ono Pharmaceutical; Takeda; Zymeworks
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Eisai (Inst); MSD (Inst); Ono Pharmaceutical (Inst); PRA Health Sciences (Inst); Taiho Pharmaceutical (Inst)
 
Takayuki Yoshino
Honoraria - Chugai Pharma; Merck; MSD K.K.; Takeda
Consulting or Advisory Role - Sumitomo Corp.
Research Funding - Amgen (Inst); Bristol-Myers Squibb Japan (Inst); Chugai Pharma (Inst); DAIICHI SANKYO COMPANY, LIMITED (Inst); Eisai (Inst); FALCO biosystems Ltd. (Inst); Medical & Biological Laboratories Co., Ltd. (Inst); Merus (Inst); Molecular Health (Inst); MSD (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Sysmex (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Jun Watanabe
Speakers' Bureau - Johnson & Johnson; Lilly; Medtronic; Takeda
Research Funding - AMCO (Inst); Medtronic (Inst); Stryker (Inst); TERUMO (Inst)
 
Hirofumi Yasui
No Relationships to Disclose
 
Hisatsugu Ohori
Honoraria - Bristol-Myers Squibb Company; DAIICHI SANKYO COMPANY, LIMITED.; Lilly Japan; MSD K.K.; Nippon Kayaku; Taiho Pharmaceutical; Takeda
 
Manabu Shiozawa
Speakers' Bureau - Johnson & Johnson; Kaken Pharmaceutical; Lilly Japan; Merck Serono; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Kei Muro
Honoraria - Bristol-Myers Squibb; Daiichi Sankyo/UCB Japan; Lilly; MSD; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Chugai Pharma; Ono Pharmaceutical
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Chugai Pharma (Inst); MSD (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); PAREXEL International (Inst); PRA Health Sciences (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst)
 
Kentaro Yamazaki
Honoraria - Bayer; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Lilly; Merck Serono; MSD; Ono Pharmaceutical; Sanofi; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Taiho Pharmaceutical (Inst)
 
Eiji Oki
Speakers' Bureau - Bristol-Myers Squibb Japan; Chugai Pharma; Lilly Japan; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda
Research Funding - Guardant Health
 
Takeo Sato
Consulting or Advisory Role - Taiho Oncology; Takeda; Takeda
Speakers' Bureau - Bayer Yakuhin; Chugai Pharma; Lilly Japan; Taiho Oncology; Takeda
 
Takeshi Naitoh
Honoraria - Chugai Pharma; Johnson & Johnson/Janssen; Medtronic; Sumitomo Chemical; Taiho Pharmaceutical (Inst)
 
Yoshito Komatsu
Speakers' Bureau - Chugai Pharma; Nihonkayaku
Research Funding - Chugai Pharma; Nihonkayaku; Nipro Corporation; Takeda
Other Relationship - Asahi Kasei; Astellas Pharma; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Chugai Pharma; Chugai Pharma; Daiichi Sankyo; Daiichi Sankyo; Eisai; EPS Associates Co., Ltd.; IQVIA; Lilly; Lilly; Merck Sharp & Dohme; Nihonkayaku; Nihonkayaku; Nippon Zoki Pharmaceutical Co.; Nipro Corporation; Ono Pharmaceutical; Ono Pharmaceutical; Pfizer; Sanofi; Shionogi; Taiho Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Pharmaceutical; Yakult Pharmaceutical
 
Takeshi Kato
Honoraria - Asahi Kasei; Chugai Pharma; Lilly Japan; Ono Pharmaceutical; Takeda
 
Junpei Soeda
Employment - Takeda
 
Kouji Yamamoto
Honoraria - AstraZeneca Japan; CM Plus; CMIC; Delta-Fly Pharma; JOHOKIKO.; Takeda; TokyoTosho
Research Funding - Chugai Pharma; Daiichi Sankyo; Kyowa Kirin; Otsuka; Taiho Pharmaceutical
 
Kiwamu Akagi
Honoraria - AstraZeneca; Chugai Pharma; Mochida Pharmaceutical Co. Ltd.; MSD; Roche Molecular Diagnostics; Taiho Pharmaceutical; Takeda
 
Atsushi Ochiai
No Relationships to Disclose
 
Katsuya Tsuchihara
Honoraria - Chugai Pharma; Lilly Japan; Takeda
Research Funding - Canon Medical System